Rescuing Mutant CFTR: A Multi-task Approach to a Better Outcome in Treating Cystic Fibrosis

E-ISSN： 1873-4286|19|19|3497-3508

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.19, 2013-06, pp. : 3497-3508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function

Current Drug Targets, Vol. 17, Iss. 11, 2016-07 ,pp. : 1275-1281

Bentham Science Publishers

Access to resources Recommend Favorite

Cystic fibrosis transmembrane regulator (CFTR) modulators

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 471-474

Informa Healthcare

Access to resources Recommend Favorite

Targeting CFTR: How to Treat Cystic Fibrosis by CFTR-Repairing Therapies

Current Drug Targets, Vol. 12, Iss. 5, 2011-05 ,pp. : 683-693

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Pharmaceutical Approaches for Treating Patients with Cystic Fibrosis

Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-01 ,pp. : 3252-3263

Bentham Science Publishers

Access to resources Recommend Favorite

Stimulation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels by flavonoids

By Illek B. Machen T.E. Widdicombe J. Fischer H.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite